DLL3 and neoplasm: The univariate analysis for PFS confirmed that patients with high DLL3 tumor expression showed a lower risk of recurrence after surgery compared with those with low DLL3 (HR: 0.55; 95%CI: 0.34–0.87; p = 0.011).